Regeneron Pharmaceuticals (REGN)

P/S ratio as of March 2025 (TTM): 5.37

According to Regeneron Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.60. At the end of 2024 the company had a P/S ratio of 5.51.

P/S ratio history for Regeneron Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	5.51	-24.44%
2023	7.29	13.02%
2022	6.45	52.74%
2021	4.23	-30.35%
2020	6.07	0.56%
2019	6.03	-0.56%
2018	6.07	-11.8%
2017	6.88	-13.65%
2016	7.97	-42.46%
2015	13.8	-7.11%
2014	14.9	14.33%
2013	13.0	7.97%
2012	12.1	4.9%
2011	11.5	79.99%
2010	6.39	23.67%
2009	5.17	-15.68%
2008	6.13	-59.74%
2007	15.2	-26.38%
2006	20.7	52.6%
2005	13.6	358.56%
2004	2.96	-79.13%
2003	14.2	-62.2%
2002	37.5	-33.51%
2001	56.3

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Amgen AMGN	4.91	-8.61%	🇺🇸 USA
Alnylam Pharmaceuticals ALNY	14.0	160.73%	🇺🇸 USA
Biogen BIIB	2.10	-60.85%	🇺🇸 USA
Johnson & Johnson JNJ	4.42	-17.69%	🇺🇸 USA
Novartis NVS	4.13	-22.99%	🇨🇭 Switzerland
Sanofi SNY	2.88	-46.37%	🇫🇷 France

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Regeneron Pharmaceuticals (REGN)

P/S ratio as of March 2025 (TTM): 5.37